Daniel Rankin

Daniel Rankin

Corporate Officer/Principal bij SWEDISH ORPHAN BIOVITRUM AB

Vermogen: 182 537 $ op 30-04-2024

44 jaar
Consumer Services
Health Technology

Oorsprong van het eerstegraads netwerk van Daniel Rankin

EntiteitType entiteitIndustrie
Public Company Pharmaceuticals: Major 48

Grafiek van bedrijven verbonden in de tweede graad

Connectie in verschillende bedrijven

Bedrijven verbonden met Daniel Rankin via zijn persoonlijke netwerk

OndernemingSectorGelieerde personenHoofdpost
Medical Specialties

Bo Jesper Hansen

Paula Treutiger

Guido Oelkers

Helena Ildiko Saxon

Director/Board Member

Public Communications Contact

Chief Executive Officer

Director/Board Member

DOVA PHARMACEUTICALS, INC. Pharmaceuticals: Major

Henrik Stenqvist

Guido Oelkers

Per Richard Torbjörn Hallberg

Mahmood Ladha

Director/Board Member

Director/Board Member

Director/Board Member

President

MEDA AB Pharmaceuticals: Major

Henrik Stenqvist

Paula Treutiger

Guido Oelkers

Director of Finance/CFO

Investor Relations Contact

Director/Board Member

Stockholm School of Economics College/University

Göran Arvidson

Helena Ildiko Saxon

Filippa Stenberg

Undergraduate Degree

Director/Board Member

Graduate Degree

Miscellaneous Commercial Services

Henrik Stenqvist

Karin Eklund Vanderpol

Mahmood Ladha

Corporate Officer/Principal

General Counsel

Director/Board Member

Pharmaceuticals: Major

Henrik Stenqvist

Guido Oelkers

Per Richard Torbjörn Hallberg

Director/Board Member

Director/Board Member

Director/Board Member

Pharmaceuticals: Major

Sven Anders Ullman

Sven Håkan Björklund

Guido Oelkers

Chief Tech/Sci/R&D Officer

President

Corporate Officer/Principal

Financial Conglomerates

Sven Anders Ullman

Sven Håkan Björklund

Guido Oelkers

Chief Tech/Sci/R&D Officer

Chief Executive Officer

Chief Operating Officer

Pharmaceuticals: Major

Sven Håkan Björklund

Guido Oelkers

Per Richard Torbjörn Hallberg

Chief Executive Officer

Corporate Officer/Principal

General Counsel

KARO PHARMA AB (PUBL) Pharmaceuticals: Major

Bo Jesper Hansen

Mats-Olof Wallin

Chairman

Director of Finance/CFO

INVESTOR AB Financial Conglomerates

Helena Ildiko Saxon

Filippa Stenberg

Director of Finance/CFO

Corporate Officer/Principal

University of Gothenburg College/University

Sven Anders Ullman

Lena Elisabeth Svanberg

Doctorate Degree

Doctorate Degree

University of Lund College/University

Per Richard Torbjörn Hallberg

Fredrik Wetterlundh

Graduate Degree

Undergraduate Degree

Copenhagen Business School College/University

Thomas Kudsk Larsen

Lars Dreiøe

Undergraduate Degree

Masters Business Admin

BAXTER INTERNATIONAL INC. Medical Specialties

Sven Anders Ullman

Theresa Heggie

Chief Tech/Sci/R&D Officer

Sales & Marketing

Ludwig-Maximilians-Universität München College/University

Armin Reininger

Anton Hoos

Doctorate Degree

Doctorate Degree

Medical Specialties

Cameron McDonough

Wills Hughes-Wilson

Corporate Officer/Principal

Corporate Officer/Principal

BAXALTA INC Biotechnology

Armin Reininger

Amy Pott

Chief Tech/Sci/R&D Officer

Corporate Officer/Principal

GSK PLC Pharmaceuticals: Major

Annette Clancy

Ravi Rao

Corporate Officer/Principal

Chief Tech/Sci/R&D Officer

SCANDIC HOTELS GROUP AB Hotels/Resorts/Cruise lines

Lena Bjurner

Fredrik Wetterlundh

Human Resources Officer

Human Resources Officer

Pharmaceuticals: Major

Theresa Heggie

Lena Elisabeth Svanberg

Corporate Officer/Principal

Corporate Officer/Principal

PHARVARIS N.V. Pharmaceuticals: Major

Johannes G. C. P. Schikan

Anne Marie de Jonge Schuermans

Founder

Director/Board Member

Miscellaneous Commercial Services

Kirsti Gjellan

Christine Wesström

Director/Board Member

Director/Board Member

HANSA BIOPHARMA AB Pharmaceuticals: Major

Göran Arvidson

Johannes G. C. P. Schikan

Chief Executive Officer

Director/Board Member

Pharmaceuticals: Generic

Mats-Olof Wallin

Kirsti Gjellan

Director of Finance/CFO

Director/Board Member

CALLIDITAS THERAPEUTICS AB Pharmaceuticals: Major

Henrik Stenqvist

Krassimir Mitchev

Director/Board Member

Chief Tech/Sci/R&D Officer

University of Uppsala College/University

Mats-Olof Wallin

Karin Eklund Vanderpol

Undergraduate Degree

Graduate Degree

H. LUNDBECK A/S Pharmaceuticals: Major

Sven Håkan Björklund

Staffan Schüberg

Chairman

Corporate Officer/Principal

ASTRAZENECA PLC Pharmaceuticals: Major

Sven Håkan Björklund

Thomas Kudsk Larsen

Corporate Officer/Principal

Investor Relations Contact

XBRANE BIOPHARMA AB Pharmaceuticals: Major

Kirsti Gjellan

Director/Board Member

ALNYLAM PHARMACEUTICALS, INC. Pharmaceuticals: Major

Theresa Heggie

Corporate Officer/Principal

AMICUS THERAPEUTICS, INC. Pharmaceuticals: Major

David Allsop

Corporate Officer/Principal

BIOCRYST PHARMACEUTICALS, INC. Biotechnology

Theresa Heggie

Director/Board Member

BIO-WORKS TECHNOLOGIES AB Biotechnology

Kirsti Gjellan

Director/Board Member

Pharmaceuticals: Major

Kirsti Gjellan

Chief Executive Officer

Coventry University College/University

David Allsop

Undergraduate Degree

SHIRE Pharmaceuticals: Major

Theresa Heggie

Corporate Officer/Principal

Pharmaceuticals: Major

Theresa Heggie

Chief Executive Officer

PROQR THERAPEUTICS N.V. Pharmaceuticals: Major

Theresa Heggie

Director/Board Member

Containers/Packaging

Kirsti Gjellan

Director/Board Member

Pharmaceuticals: Major

Theresa Heggie

Chief Executive Officer

Biotechnology

Theresa Heggie

Director/Board Member

Belnor BVBA

Hege Hellstrom

Founder

Arden Regulatory Clinical & Medical Consulting Ltd.

Krassimir Mitchev

Director/Board Member

INFLARX N.V. Biotechnology

Hege Hellstrom

Director/Board Member

Statistieken

Internationaal

Zweden 24
Verenigde Staten 10
Verenigd Koninkrijk 7
Denemarken 4
Nederland 4

Sectoraal

Health Technology 33
Consumer Services 9
Commercial Services 4
Finance 4
Process Industries 2

Operationeel

Director/Board Member 175
Corporate Officer/Principal 84
Independent Dir/Board Member 63
Chairman 44
Chief Executive Officer 30
  1. Beurs
  2. Insiders
  3. Daniel Rankin
  4. Bedrijfsconnecties
-40 % Uitzonderlijk verlengd: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU